NewsRoom Articles - Page 437 of 1255

TuesdaySep 01, 2020 11:00 am

iCAD Inc. (NASDAQ: ICAD) Starts Presentation at The LD 500

iCAD Inc. (NASDAQ: ICAD) is a global medical technology leader providing innovative cancer detection and therapy solutions. The company works passionately to provide precise, powerful health care solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes. iCAD offers a comprehensive range of computer-aided detection (CAD) and workflow solutions to support rapid and accurate detection of breast and colorectal cancers. The comprehensive iCAD technology platforms include advanced hardware and software designed to support cancer detection and radiation therapy treatments. For more information, visit the company's website at www.icadmed.com About The LD 500 The LD 500 is the most…

TuesdaySep 01, 2020 11:00 am

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Starts Presentation at The LD 500

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is a late-stage specialty pharmaceutical company dedicated to the development and commercialization of critical care products, with a focus on anti-infectives and cancer care. Citius is focused on the development and commercialization of important new drug products for growing markets. The company is currently advancing three proprietary product candidates: Mino-Lok(R), CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Citius believes the markets for its products are large and underserved by the current standard of care. For more information, visit the company's website at www.citiuspharma.com About The LD 500 The LD 500 is the most ambitious project in…

TuesdaySep 01, 2020 11:00 am

BioLargo Inc. (OTCQB: BLGO) Starts Presentation at The LD 500

BioLargo Inc. (OTCQB: BLGO) is a sustainable science, technology and full-service environmental engineering company that "makes life better" by delivering world-class products and services across a broad range of industries. As an innovator of technology-based products and sustainable environmental engineering solutions, BioLargo is driven to deliver clean water, clean air and advanced antimicrobials for health care. The BioLargo family of companies includes BioLargo Engineering, Science & Technologies; BioLargo Water; Clyra Medical Technologies Inc.; and Odor-No-More (ONM) Environmental Products and Services. For more information, visit the company's website at www.biolargo.com About The LD 500 The LD 500 is the most ambitious…

TuesdaySep 01, 2020 10:40 am

Vuzix Corp. (NASDAQ: VUZI) Starts Presentation at The LD 500

Vuzix Corp. (NASDAQ: VUZI) is a leading supplier of smart-glasses and augmented reality (AR) technologies and products for the consumer and enterprise markets. The company's products include personal display and wearable computing devices that offer users a portable, high-quality viewing experience and provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 166 issued and pending patents and numerous IP licenses in the video eyewear field. The company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards, among others. For more information, visit the company's website…

TuesdaySep 01, 2020 10:40 am

Theralink Technologies Inc. (OTC: OBMP) Starts Presentation at The LD 500

Theralink Technologies Inc. (OTC: OBMP) is a proteomics-based molecular profiling company that uniquely specializes in phospohoprotein and protein biomarker assay services that target multiple areas of oncology. Theralink provides precision oncology data through its powerful Theralink Reverse Phase Protein Array (RPPA) assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to both FDA-approved and investigational drug treatments. The company intends to improve cancer outcomes for patients, reveal therapeutic options for oncologists and support biopharmaceutical drug development by using a beyond-genomics approach to molecular profiling that directly measures drug target levels and activity. For more…

TuesdaySep 01, 2020 10:40 am

Xpel Inc. (NASDAQ: XPEL) Starts Presentation at The LD 500

XPEL Inc. (NASDAQ: XPEL) is a leading provider of protective films and coatings, including automotive paint protection film, surface protection film, automotive and commercial/residential window films and ceramic coatings. With a global footprint, a network of trained installers and proprietary DAP software, XPEL is dedicated to exceeding customer expectations by providing high-quality products, leading customer service, expert technical support and world-class training. For more information, visit the company's website at www.xpel.com About The LD 500 The LD 500 is the most ambitious project in LD Micro's 14-year history of leading the micro-cap space as an independent resource. Investors will enjoy…

TuesdaySep 01, 2020 10:20 am

Artelo Biosciences Inc. (NASDAQ: ARTL) Starts Presentation at The LD 500

Artelo Biosciences Inc. (NASDAQ: ARTL) is a biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system and related biological signaling pathways. Artelo is applying true biopharma discipline toward rapidly advancing a diverse portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the company applies leading edge scientific, regulatory and commercial discipline to develop high-impact therapies. For more information, visit the company's website at www.artelobio.com About The LD…

TuesdaySep 01, 2020 10:20 am

BioCardia Inc. (NASDAQ: BCDA) Starts Presentation at The LD 500

BioCardia Inc. (NASDAQ: BCDA) is a clinical-stage regenerative medicine company. Headquartered in San Carlos, California, BioCardia is developing regenerative biologic therapies to treat cardiovascular disease. The company's CardiAMP autologous and NK1R+ allogenic cell therapies are biotherapeutic platforms currently in clinical development. BioCardia's products include the Helix biotherapeutic delivery system and its steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix system and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction. For more information, visit the company's website at www.biocardia.com About…

TuesdaySep 01, 2020 10:20 am

Nephros Inc. (NASDAQ: NEPH) Starts Presentation at The LD 500

Nephros Inc. (NASDAQ: NEPH) is a commercial-stage company that develops and markets high-performance water purification products and pathogen detection systems for medical and commercial markets. Nephros ultrafilters are used in hospitals, medical clinics and commercial facilities to retain bacteria and viruses from water, providing barriers that aid in infection control for showers, sinks and ice machines. Nephros pathogen detection systems, including the PluraPath and SequaPath systems, provide near-real time information on bacterial genera, waterborne bacteria and viruses to medical and water safety professionals. These products integrate Nephros ultrafilters with DNA sequencing and quantitative polymerase chain reaction (qPCR) technology. Nephros and…

TuesdaySep 01, 2020 10:20 am

OpSens Inc. (TSX: OPS) (OTCQX: OPSSF) Starts Presentation at The LD 500

OpSens Inc. (TSX: OPS) (OTCQX: OPSSF) focuses mainly on coronary physiology products in interventional cardiology. OpSens offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and excellent lesions access. The OptoWire has been used in the diagnosis and treatment of over 100,000 patients in more than 30 countries. It is approved for sale in the United States, European Union, Japan and Canada. OpSens is also involved in industrial activities…